Literature DB >> 4799208

Studies on live mumps virus vaccine. V. Development of a new mumps vaccine "AM 9" by plaque cloning.

K Yamanishi, M Takahashi, S Ueda, Y Minekawa, T Ogino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4799208

Source DB:  PubMed          Journal:  Biken J        ISSN： 0006-2324


× No keyword cloud information.
  9 in total

1.  Recent mumps outbreaks in vaccinated populations: no evidence of immune escape.

Authors:  Steven A Rubin; Malen A Link; Christian J Sauder; Cheryl Zhang; Laurie Ngo; Bert K Rima; W Paul Duprex
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  Nucleotide sequence at position 1081 of the hemagglutinin-neuraminidasegene in wild-type strains of mumps virus is the most relevant marker of virulence.

Authors:  M G Cusi; L Santini; S Bianchi; M Valassina; P E Valensin
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

3.  In vitro secondary generation of cytotoxic T lymphocytes in mice with mumps virus and their mumps-specific cytotoxicity among paramyxoviruses.

Authors:  Y Hosaka; Y Yasuda; O Seriburi; M G Moran; K Fukai
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

Review 4.  [Mumps vaccines: virological basis].

Authors:  A Ströhle; D Germann
Journal:  Soz Praventivmed       Date:  1995

5.  Enzyme-linked immunosorbent assay compared with neutralization tests for evaluation of live mumps vaccines.

Authors:  H Sakata; M Hishiyama; A Sugiura
Journal:  J Clin Microbiol       Date:  1984-01       Impact factor: 5.948

6.  Evaluation of a neonatal rat model for prediction of mumps virus neurovirulence in humans.

Authors:  S A Rubin; M Pletnikov; R Taffs; P J Snoy; D Kobasa; E G Brown; K E Wright; K M Carbone
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

7.  Prime-boost vaccination with recombinant mumps virus and recombinant vesicular stomatitis virus vectors elicits an enhanced human immunodeficiency virus type 1 Gag-specific cellular immune response in rhesus macaques.

Authors:  R Xu; F Nasar; S Megati; A Luckay; M Lee; S A Udem; J H Eldridge; M A Egan; E Emini; D K Clarke
Journal:  J Virol       Date:  2009-07-22       Impact factor: 5.103

8.  Antigenic differences between vaccine and circulating wild-type mumps viruses decreases neutralization capacity of vaccine-induced antibodies.

Authors:  M Šantak; M Lang-Balija; J Ivancic-Jelecki; T Košutić-Gulija; S Ljubin-Sternak; D Forcic
Journal:  Epidemiol Infect       Date:  2012-09-07       Impact factor: 4.434

Review 9.  Mumps Outbreaks in Vaccinated Populations-Is It Time to Re-assess the Clinical Efficacy of Vaccines?

Authors:  Anna R Connell; Jeff Connell; T Ronan Leahy; Jaythoon Hassan
Journal:  Front Immunol       Date:  2020-09-18       Impact factor: 7.561
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.